Kosovar doctor, Arber Shehu, from November 28 will exercise his work as a director in one of the best biopharmaceutical companies in the world “AstraZeneca”.

The news was announced by Shehu himself through a post on Instagram.

Effective November 28, I will be joining one of the world’s top biopharmaceutical companies, ASTRAZENECA, as Associate Medical Director/US Medical Director of Oncology, Medical Affairs,” he wrote.

Meanwhile, Arbër Shehu is not an unheard of name in American medicine.

From a survivor of the Serbian genocide, to an excellent medical student at the University of Pristina, after clinical work as a doctor in Kosovo, he was accepted to continue his postgraduate studies in medical sciences at James Madison University, in the state of Virginia, USA -‘s.

After graduation, he secured a position at Johns Hopkins University, School of Medicine, in the Department of Pulmonary Diseases and Intensive Care, managing and coordinating a new scientific research laboratory that was established to conduct research that informs the best practices. good luck to the doctors treating COVID-19.

After work and collaborations with many other hospital centers between the group he works, and in close collaboration with the Center for Disease Control (CDC) in the USA, Shehu also became one of the authors of a study on the effectiveness of Pfizer and Moderna vaccines. In the last year alone, they published more than 10 scientific papers in prestigious world journals, which continuously informed the CDC, the Department of Health and the Administration of President Biden, regarding the effectiveness of Covid-19 vaccines in preventing hospitalization, mechanical ventilation and death.